A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.
about
Fibroblast growth factor 23Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?Magnesium in CKD: more than a calcification inhibitor?A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats.Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.Magnesium: a renewed player of vascular ageing in diabetic CKD patients?Serum Magnesium and Sudden Death in European Hemodialysis PatientsCKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.Sevelamer carbonate: a review in hyperphosphataemia in adults with chronic kidney disease.Next-generation phosphate binders: focus on iron-based binders.Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.The challenge of controlling phosphorus in chronic kidney disease.Magnesium and cardiovascular complications of chronic kidney disease.Contemporary management of phosphorus retention in chronic kidney disease: a review.Advances in pharmacotherapy for secondary hyperparathyroidism.Phosphate Binders and Clinical Outcomes in Patients with Stage 5D Chronic Kidney Disease.Clinical features of CKD-MBD in Japan: cohort studies and registry.Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients.Clinical aspects of magnesium physiology in patients on dialysis.Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.Magnesium supplementation: A consideration in dialysis patients.Optimal phosphate control: still an unmet need in chronic kidney disease patientsTreatment of hyperphosphatemia based on specific interactions between phosphorus and Zr(iv) active centers of nano-MOFs
P2860
Q26829294-9CB55971-6C33-45C1-9E50-F8E7C8748F1FQ27002431-EC09EF9A-6469-4C0D-B468-F0582476071DQ27027086-A35ED947-985F-4454-B92F-9067089D7B87Q34205168-A1F1DD28-FF7B-4C83-8CFD-DCB45AC99DF0Q34784711-39AAF8AB-DBF7-45CA-837B-C94C68F7393CQ35227651-65471B7F-1AC5-46F9-9E97-533F458988F3Q35850564-52B1BE92-858D-44B4-9F76-35DEEB830120Q37279085-A69ED010-9A6C-42E1-8008-8478A40470EBQ38200883-1A87EE1B-6EAE-47FE-ACD5-600C53A4373AQ38202179-E68ECF23-7D2D-4C6A-8F0B-8033A8E349DDQ38210438-937FA075-B42F-4B79-A655-1E415E3BCAE7Q38213502-E8767E7F-3AB9-41E0-A2EB-3DA5AB0A8F84Q38253227-EDE8BF88-4EDC-4850-91D8-A43318DFA71DQ38377286-501E9EF1-4D73-4790-9CC2-66F3760704BEQ38473932-392BB862-9494-43F6-A644-1D307A932E6DQ38511621-FE9BDFE4-6BCF-4CBE-B280-6BA03ABC6557Q38544533-A46FD4CD-3B35-496B-BE98-964053DE5313Q38567745-7A0F9C94-CC03-49F6-8DA1-E091F23A7EBCQ38784139-AD2382DA-2198-42A1-B1A9-14F2396E539CQ38828902-6A615416-CFD5-4F01-814A-E7E314211347Q39369106-EB099882-FB97-4260-A489-898807EE94D0Q39369171-546AE65B-5D93-4352-9AA8-64345847106AQ40429347-925E2B6D-2474-42AA-B6C7-C4B5A6862C05Q50074589-4AC8B971-18DF-4059-8059-DD7DB32A1484Q57217288-2812D436-4068-48EE-B355-00710FD4F096Q57470029-C977F22C-1CB0-40D9-9DC7-009040B7283B
P2860
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A comparison of calcium acetat ...... controlled, randomized study.
@en
A comparison of calcium acetat ...... controlled, randomized study.
@nl
type
label
A comparison of calcium acetat ...... controlled, randomized study.
@en
A comparison of calcium acetat ...... controlled, randomized study.
@nl
prefLabel
A comparison of calcium acetat ...... controlled, randomized study.
@en
A comparison of calcium acetat ...... controlled, randomized study.
@nl
P2093
P2860
P356
P1476
A comparison of calcium acetat ...... controlled, randomized study.
@en
P2093
Adrian Ghenu
Angel L M de Francisco
Barbara Marzell
Beatrix Büschges-Seraphin
Jutta Passlick-Deetjen
Miroslaw Kroczak
Pedro Ponce
P2860
P304
P356
10.1093/NDT/GFT203
P407
P50
P577
2013-06-19T00:00:00Z